Fluoroalkylamine derivatives as cathepsin inhibitors

Details for Australian Patent Application No. 2006254674 (hide)

Owner Merck Frosst Canada Ltd.

Inventors Gauthier, Jacques Yves; Black, Cameron

Agent Spruson & Ferguson

Pub. Number AU-A-2006254674

PCT Pub. Number WO2006/128287

Priority 60/686,813 02.06.05 US

Filing date 30 May 2006

Wipo publication date 7 December 2006

International Classifications

C07C 317/50 (2006.01) Sulfones

A61K 31/275 (2006.01) - Nitriles

Event Publications

13 December 2007 PCT application entered the National Phase

  PCT publication WO2006/128287 Priority application(s): WO2006/128287

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006254675-Formulation comprising farnesyl dibenzodiazepinone and a pharmaceutically acceptable surfactant

2006254673-A system for the conversion of coal to a gas of a specified composition